Aurobindo joins hands with global pharma player to develop respiratory products
Aurobindo Pharma on Saturday said its US-based subsidiary has inked a licensing agreement with a global pharma major for development of respiratory products. Aurobindo Pharma USA Inc has entered into a collaboration and licence agreement with a global pharma major for development and commercialisation of products, the Hyderabad-based drug firm said in a regulatory filing.
Maharashtra Election Results
Jharkhand Election Results
Bypoll Election Results
The partnership is for an initial estimated development duration of three-five years, it added.
As per the pact, both parties will co-exclusively commercialise the products.
The products, once commercialised, will be manufactured at Partner's facility and will be marketed by both parties, Aurobindo Pharma said.
Besides a cost-sharing arrangement has been agreed by both the parties with each of them contributing 50 per cent of the cost incurred with an overall cap of USD 90 million for Aurobindo over the development period, it said.
Web Development
JavaScript Essentials: Unlock AI-Driven Insights with ChatGPT
By — Metla Sudha Sekhar, IT Specialist and Developer
Leadership
Building Your Winning Startup Team: Key Strategies for Success
By — Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience
Finance
AI and Generative AI for Finance
By — Hariom Tatsat, Vice President- Quantitative Analytics at Barclays
Finance
Crypto & NFT Mastery: From Basics to Advanced
By — CA Raj K Agrawal, Chartered Accountant
Artificial
